Pevonedistat plus belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome: A phase I multicenter study

被引：0
|
作者：
Maher, Keri Renee
Schafer, Danielle
Schaar, Dale
Sabo, Roy
Bandyopadhyay, Dipankar
Grant, Steven
机构：
[1] VCU Massey Canc Ctr, Richmond, VA USA
[2] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[3] Virginia Commonwealth Univ, Richmond, VA USA
[4] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19015
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia
    Sekiguchi, Naohiro
    Kasahara, Senji
    Miyamoto, Toshihiro
    Kiguchi, Toru
    Ohno, Hitoshi
    Takagi, Taiga
    Tachibana, Masaya
    Sumi, Hiroyuki
    Kakurai, Yasuyuki
    Yamashita, Tomonari
    Usuki, Kensuke
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (01) : 68 - 77
  • [32] A phase I study of ENMD-2076 in patients with relapsed or refractory acute myeloid leukemia (AML)
    Yee, Karen W.
    Brandwein, Joseph
    Minden, Mark D.
    Sanfelice, Deborah
    Chow, Sue
    Hedley, David W.
    Schimmer, Aaron D.
    Schuh, Andre C.
    Gupta, Vikas
    Sidor, Carolyn F.
    Arnott, Jamie
    Fletcher, Graham
    Bray, Mark
    Chen, Hsiao-Wei Tina
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [33] Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia
    Naohiro Sekiguchi
    Senji Kasahara
    Toshihiro Miyamoto
    Toru Kiguchi
    Hitoshi Ohno
    Taiga Takagi
    Masaya Tachibana
    Hiroyuki Sumi
    Yasuyuki Kakurai
    Tomonari Yamashita
    Kensuke Usuki
    International Journal of Hematology, 2023, 117 : 68 - 77
  • [34] How I treat refractory and relapsed acute myeloid leukemia
    Thol, Felicitas
    Doehner, Hartmut
    Ganser, Arnold
    BLOOD, 2024, 143 (01) : 11 - 20
  • [35] A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia
    Canaani, Jonathan
    Danylesko, Ivetta
    Shemtov, Noga
    Zlotnick, Maya
    Lozinsky, Kira
    Benjamini, Ohad
    Yerushalmi, Ronit
    Nagar, Meital
    Dor, Chen
    Shimoni, Avichai
    Avigdor, Abraham
    Nagler, Arnon
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (02) : 260 - 266
  • [36] A Phase II Study of Bisantrene in Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Canaani, Jonathan
    Danilesko, Ivetta
    Shem-Tov, Noga
    Zlotnick, Maya
    Lozinsky, Kira
    Benjamini, Ohad
    Yerushalmi, Ronit
    Nagar, Meital
    Dor, Chen
    Shimoni, Avichai
    Avigdor, Abraham
    Nagler, Arnon
    BLOOD, 2020, 136
  • [37] A Phase I/IIa Study of Lemzoparlimab, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Initial Phase I Results
    Qi, Junyuan
    Li, Jian
    Jiang, Bin
    Jiang, Bo
    Liu, Hongzhong
    Cao, Xinxin
    Zhang, Meixiang
    Meng, Yuan
    Ma, Xiaoyu
    Jia, Yingmin
    Guo, Jiyuan
    Zhang, Yanni
    Huang, Wei
    Wang, Jianxiang
    BLOOD, 2020, 136
  • [38] Phase I and Extension Study of Clofarabine Plus Cyclophosphamide in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
    Faderl, Stefan
    Balakrishnan, Kumudha
    Thomas, Deborah A.
    Ravandi, Farhad
    Borthakur, Gautam
    Burger, Jan
    Ferrajoli, Alessandra
    Cortes, Jorge
    O'Brien, Susan
    Kadia, Tapan
    Feliu, Jennie
    Plunkett, William
    Gandhi, Varsha
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (03): : 231 - 238
  • [39] A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia
    Abdel-Karim, Isam
    Plunkett, William K., Jr.
    O'Brien, Susan
    Giles, Francis
    Thomas, Deborah
    Faderl, Stefan
    Ravandi, Farhad
    Rios, Mary Beth
    Du, Min
    Schneck, Karen B.
    Chen, Victor J.
    Lin, Boris K.
    Nicol, Steven J.
    Kantarjian, Hagop M.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (02) : 323 - 331
  • [40] Phase I study of temozolomide in relapsed/refractory acute leukemia.
    Seiter, K
    Liu, DL
    Loughran, T
    Siddiqui, D
    Kancherla, R
    Ahmed, T
    BLOOD, 2001, 98 (11) : 222B - 222B
12345